$BGNE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BeiGene, Ltd.. Get notifications about new insider transactions in BeiGene, Ltd. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 8 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 192.08 | 1,800 | 345,752 | 0 | 1.8 K to 0 (-100.00 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 191.10 | 2,016 | 385,265 | 1,800 | 3.8 K to 1.8 K (-52.83 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 193.68 | 35 | 6,779 | 0 | 35 to 0 (-100.00 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 192.84 | 1,100 | 212,128 | 35 | 1.1 K to 35 (-96.92 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 191.56 | 300 | 57,468 | 1,135 | 1.4 K to 1.1 K (-20.91 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 191.23 | 300 | 57,368 | 0 | 300 to 0 (-100.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 461,075 | |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 12.34 | 27,027 | 333,513 | 283,153 | |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 193.56 | 100 | 19,356 | 0 | 100 to 0 (-100.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 192.72 | 198 | 38,158 | 100 | 298 to 100 (-66.44 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 191.37 | 500 | 95,685 | 298 | 798 to 298 (-62.66 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 188.95 | 402 | 75,959 | 798 | 1.2 K to 798 (-33.50 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 187.91 | 300 | 56,373 | 1,200 | 1.5 K to 1.2 K (-20.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 192.46 | 435 | 83,720 | 0 | 435 to 0 (-100.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 200.30 | 700 | 140,208 | 0 | 700 to 0 (-100.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 200.29 | 700 | 140,204 | 700 | 1.4 K to 700 (-50.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 200.27 | 679 | 135,985 | 1,400 | 2.1 K to 1.4 K (-32.66 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 160.40 | 2,079 | 333,472 | 2,079 | 0 to 2.1 K |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 189.42 | 1,725 | 326,745 | 0 | 1.7 K to 0 (-100.00 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 188.20 | 3,800 | 715,163 | 1,725 | 5.5 K to 1.7 K (-68.78 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 187.10 | 4,115 | 769,914 | 5,525 | 9.6 K to 5.5 K (-42.69 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 186.11 | 4,741 | 882,334 | 9,640 | 14.4 K to 9.6 K (-32.97 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 188.43 | 410 | 77,258 | 14,381 | 14.8 K to 14.4 K (-2.77 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 187.46 | 7,438 | 1,394,335 | 14,791 | 22.2 K to 14.8 K (-33.46 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 186.63 | 4,922 | 918,569 | 22,229 | 27.2 K to 22.2 K (-18.13 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 185.54 | 1,610 | 298,712 | 27,151 | 28.8 K to 27.2 K (-5.60 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 184.56 | 690 | 127,348 | 28,761 | 29.5 K to 28.8 K (-2.34 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 183.72 | 3,095 | 568,601 | 29,451 | 32.5 K to 29.5 K (-9.51 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 182.78 | 3,714 | 678,839 | 32,546 | 36.3 K to 32.5 K (-10.24 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 181.79 | 1,772 | 322,138 | 36,260 | 38 K to 36.3 K (-4.66 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 180.50 | 800 | 144,401 | 38,032 | 38.8 K to 38 K (-2.06 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 179.59 | 900 | 161,626 | 38,832 | 39.7 K to 38.8 K (-2.27 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 187.36 | 700 | 131,154 | 0 | 700 to 0 (-100.00 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 186.62 | 3,455 | 644,756 | 700 | 4.2 K to 700 (-83.15 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 185.58 | 1,845 | 342,388 | 4,155 | 6 K to 4.2 K (-30.75 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 183.38 | 180 | 33,009 | 0 | 180 to 0 (-100.00 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 182.52 | 800 | 146,016 | 180 | 980 to 180 (-81.63 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 181.52 | 2,220 | 402,982 | 980 | 3.2 K to 980 (-69.37 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 180.37 | 1,800 | 324,666 | 3,200 | 5 K to 3.2 K (-36.00 %) |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 13.42 | 90,766 | 1,218,080 | 90,766 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | HOOPER ANTHONY C | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | su Jingshyh S | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | A | 13.42 | 273,286 | 3,667,498 | 273,286 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Grant | A | 0.00 | 48,438 | 0 | 331,902 | 283.5 K to 331.9 K (+17.09 %) |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | A | 13.42 | 315,341 | 4,231,876 | 315,341 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Grant | A | 0.00 | 55,887 | 0 | 172,315 | 116.4 K to 172.3 K (+48.00 %) |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Option Exercise | A | 13.42 | 756,821 | 10,156,538 | 756,821 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Grant | A | 0.00 | 134,147 | 0 | 1,514,562 | 1.4 M to 1.5 M (+9.72 %) |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Option Exercise | A | 13.42 | 1,821,976 | 24,450,918 | 1,821,976 | |
| Jun 12 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 175.07 | 900 | 157,563 | 0 | 900 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 170.84 | 453 | 77,391 | 0 | 453 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 171.98 | 475 | 81,691 | 0 | 475 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 171.20 | 1,125 | 192,605 | 475 | 1.6 K to 475 (-70.31 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 170.02 | 1,200 | 204,022 | 1,600 | 2.8 K to 1.6 K (-42.86 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 170.84 | 631 | 107,800 | 0 | 631 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 172.46 | 200 | 34,492 | 0 | 200 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 171.43 | 2,300 | 394,277 | 200 | 2.5 K to 200 (-92.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 170.48 | 3,500 | 596,686 | 2,500 | 6 K to 2.5 K (-58.33 %) |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 480,575 | |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 165.12 | 431 | 71,168 | 0 | 431 to 0 (-100.00 %) |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 163.97 | 569 | 93,300 | 431 | 1,000 to 431 (-56.90 %) |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 162.63 | 500 | 81,316 | 1,000 | 1.5 K to 1,000 (-33.33 %) |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |
| May 21 2020 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 169.84 | 10,000 | 1,698,400 | 0 | 10 K to 0 (-100.00 %) |
| May 21 2020 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Gift | G | 0.00 | 2,680 | 0 | 3,497,678 | 3.5 M to 3.5 M (-0.08 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 141.00 | 474 | 66,834 | 0 | 474 to 0 (-100.00 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 140.96 | 2,859 | 403,005 | 474 | 3.3 K to 474 (-85.78 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 143.17 | 302 | 43,237 | 3,333 | 3.6 K to 3.3 K (-8.31 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 142.46 | 1,000 | 142,462 | 3,635 | 4.6 K to 3.6 K (-21.57 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 141.00 | 245 | 34,545 | 0 | 245 to 0 (-100.00 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 143.17 | 300 | 42,952 | 245 | 545 to 245 (-55.05 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 142.54 | 1,224 | 174,469 | 545 | 1.8 K to 545 (-69.19 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 140.96 | 5,255 | 740,745 | 1,769 | 7 K to 1.8 K (-74.81 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 141.00 | 474 | 66,834 | 0 | 474 to 0 (-100.00 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 140.96 | 2,859 | 403,005 | 474 | 3.3 K to 474 (-85.78 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 143.17 | 302 | 43,237 | 3,333 | 3.6 K to 3.3 K (-8.31 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 142.46 | 1,000 | 142,462 | 3,635 | 4.6 K to 3.6 K (-21.57 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 141.00 | 245 | 34,545 | 0 | 245 to 0 (-100.00 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 143.17 | 300 | 42,952 | 245 | 545 to 245 (-55.05 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 142.54 | 1,224 | 174,469 | 545 | 1.8 K to 545 (-69.19 %) |
| May 05 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 140.96 | 5,255 | 740,745 | 1,769 | 7 K to 1.8 K (-74.81 %) |
| Mar 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 158.63 | 201 | 31,884 | 0 | 201 to 0 (-100.00 %) |
| Mar 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 157.51 | 1,768 | 278,476 | 201 | 2 K to 201 (-89.79 %) |
| Mar 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 156.82 | 3,031 | 475,321 | 1,969 | 5 K to 2 K (-60.62 %) |
| Mar 06 2020 | BGNE | BeiGene, Ltd. | HOOPER ANTHONY C | Director | Option Exercise | A | 12.22 | 21,970 | 268,473 | 21,970 | |
| Feb 20 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 539,075 | |
| Feb 20 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 171.14 | 321 | 54,935 | 0 | 321 to 0 (-100.00 %) |
| Feb 20 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 170.01 | 1,179 | 200,445 | 321 | 1.5 K to 321 (-78.60 %) |
| Feb 20 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |
| Jan 22 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 558,575 | |
| Jan 22 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 172.34 | 87 | 14,994 | 0 | 87 to 0 (-100.00 %) |
| Jan 22 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 171.27 | 600 | 102,762 | 87 | 687 to 87 (-87.34 %) |
| Jan 22 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 170.10 | 813 | 138,287 | 687 | 1.5 K to 687 (-54.20 %) |
| Jan 22 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |
| Dec 19 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 165.61 | 1,958 | 324,263 | 0 | 2 K to 0 (-100.00 %) |
| Dec 19 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 163.20 | 200 | 32,640 | 1,958 | 2.2 K to 2 K (-9.27 %) |
| Dec 19 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 162.42 | 2,400 | 389,796 | 2,158 | 4.6 K to 2.2 K (-52.65 %) |
| Dec 19 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 161.49 | 18,215 | 2,941,528 | 4,558 | 22.8 K to 4.6 K (-79.99 %) |
| Dec 19 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 160.60 | 16,965 | 2,724,572 | 22,773 | 39.7 K to 22.8 K (-42.69 %) |
| Dec 19 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 159.59 | 15,466 | 2,468,196 | 39,738 | 55.2 K to 39.7 K (-28.02 %) |
| Dec 19 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 158.63 | 7,055 | 1,119,105 | 55,204 | 62.3 K to 55.2 K (-11.33 %) |
| Dec 18 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 578,075 | |
| Dec 18 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 173.59 | 100 | 17,359 | 0 | 100 to 0 (-100.00 %) |
| Dec 18 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 172.13 | 100 | 17,213 | 100 | 200 to 100 (-50.00 %) |
| Dec 18 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 170.73 | 200 | 34,145 | 200 | 400 to 200 (-50.00 %) |
| Dec 18 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 168.90 | 100 | 16,890 | 400 | 500 to 400 (-20.00 %) |
| Dec 18 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 165.55 | 100 | 16,555 | 500 | 600 to 500 (-16.67 %) |
| Dec 18 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 161.93 | 800 | 129,541 | 600 | 1.4 K to 600 (-57.14 %) |
| Dec 18 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 160.07 | 100 | 16,007 | 1,400 | 1.5 K to 1.4 K (-6.67 %) |
| Dec 18 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |
| Nov 22 2019 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Gift | G | 0.00 | 81,060 | 0 | 3,630,366 | 3.7 M to 3.6 M (-2.18 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 325,000 | 162,500 | 3,795,000 | |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 198.93 | 400 | 79,572 | 0 | 400 to 0 (-100.00 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 197.55 | 200 | 39,510 | 400 | 600 to 400 (-33.33 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 196.63 | 200 | 39,326 | 600 | 800 to 600 (-25.00 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 195.57 | 5,633 | 1,101,671 | 800 | 6.4 K to 800 (-87.56 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 194.62 | 8,156 | 1,587,311 | 6,433 | 14.6 K to 6.4 K (-55.91 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 193.60 | 6,944 | 1,344,334 | 14,589 | 21.5 K to 14.6 K (-32.25 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 192.63 | 2,311 | 445,168 | 21,533 | 23.8 K to 21.5 K (-9.69 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 191.80 | 1,156 | 221,724 | 23,844 | 25 K to 23.8 K (-4.62 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 25,000 | 162,500 | 25,000 | 0 to 25 K |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 597,575 | |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 198.93 | 100 | 19,893 | 0 | 100 to 0 (-100.00 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 195.82 | 95 | 18,603 | 100 | 195 to 100 (-48.72 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 195.01 | 605 | 117,983 | 195 | 800 to 195 (-75.62 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 193.63 | 500 | 96,813 | 800 | 1.3 K to 800 (-38.46 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 192.24 | 200 | 38,448 | 1,300 | 1.5 K to 1.3 K (-13.33 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 202.05 | 395 | 79,810 | 0 | 395 to 0 (-100.00 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 193.57 | 2,605 | 504,242 | 395 | 3 K to 395 (-86.83 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 202.05 | 1,496 | 302,267 | 0 | 1.5 K to 0 (-100.00 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 196.87 | 100 | 19,687 | 1,496 | 1.6 K to 1.5 K (-6.27 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 195.86 | 300 | 58,757 | 1,596 | 1.9 K to 1.6 K (-15.82 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 195.14 | 1,900 | 370,774 | 1,896 | 3.8 K to 1.9 K (-50.05 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 194.12 | 704 | 136,662 | 3,796 | 4.5 K to 3.8 K (-15.64 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 193.04 | 2,200 | 424,692 | 4,500 | 6.7 K to 4.5 K (-32.84 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 192.19 | 2,500 | 480,482 | 6,700 | 9.2 K to 6.7 K (-27.17 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 191.03 | 800 | 152,826 | 9,200 | 10 K to 9.2 K (-8.00 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Grant | A | 0.00 | 50 | 0 | 50 | 0 to 50 |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | J | 0.00 | 50 | 0 | 4,903,998 | 4.9 M to 4.9 M (0.00 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 202.05 | 1,000 | 202,050 | 0 | 1,000 to 0 (-100.00 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 427,700 | 970,879 | 617,075 | |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 192.77 | 300 | 57,831 | 0 | 300 to 0 (-100.00 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 191.96 | 2,854 | 547,844 | 300 | 3.2 K to 300 (-90.49 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 191.01 | 12,654 | 2,417,011 | 3,154 | 15.8 K to 3.2 K (-80.05 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 190.00 | 12,523 | 2,379,399 | 15,808 | 28.3 K to 15.8 K (-44.20 %) |